Literature DB >> 24990759

Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma.

Michael J Kelley1, Jianxin Shi, Bari Ballew, Paula L Hyland, Wen-Qing Li, Melissa Rotunno, David A Alcorta, Norbert J Liebsch, Jason Mitchell, Sara Bass, David Roberson, Joseph Boland, Michael Cullen, Ji He, Laurie Burdette, Meredith Yeager, Stephen J Chanock, Dilys M Parry, Alisa M Goldstein, Xiaohong R Yang.   

Abstract

Chordoma is a rare bone cancer that is believed to originate from notochordal remnants. We previously identified germline T duplication as a major susceptibility mechanism in several chordoma families. Recently, a common genetic variant in T (rs2305089) was significantly associated with the risk of sporadic chordoma. We sequenced all T exons in 24 familial cases and 54 unaffected family members from eight chordoma families (three with T duplications), 103 sporadic cases, and 160 unrelated controls. We also measured T copy number variation in all sporadic cases. We confirmed the association between the previously reported variant rs2305089 and risk of familial [odds ratio (OR) = 2.6, 95% confidence interval (CI) = 0.93, 7.25, P = 0.067] and sporadic chordoma (OR = 2.85, 95% CI = 1.89, 4.29, P < 0.0001). We also identified a second common variant, rs1056048, that was strongly associated with chordoma in families (OR = 4.14, 95% CI = 1.43, 11.92, P = 0.0086). Among sporadic cases, another common variant (rs3816300) was significantly associated with risk when jointly analyzed with rs2305089. The association with rs3816300 was significantly stronger in cases with early age onset. In addition, we identified three rare variants that were only observed among sporadic chordoma cases, all of which have potential functional relevance based on in silico predictions. Finally, we did not observe T duplication in any sporadic chordoma case. Our findings further highlight the importance of the T gene in the pathogenesis of both familial and sporadic chordoma and suggest a complex susceptibility related to T.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24990759      PMCID: PMC6938388          DOI: 10.1007/s00439-014-1463-z

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  Chordoma: incidence and survival patterns in the United States, 1973-1995.

Authors:  M L McMaster; A M Goldstein; C M Bromley; N Ishibe; D M Parry
Journal:  Cancer Causes Control       Date:  2001-01       Impact factor: 2.506

2.  Incidence and survival patterns of cranial chordoma in the United States.

Authors:  Kyle J Chambers; Derrick T Lin; Josh Meier; Aaron Remenschneider; Marc Herr; Stacey T Gray
Journal:  Laryngoscope       Date:  2013-10-29       Impact factor: 3.325

3.  Clinical and pathologic review of 48 cases of chordoma.

Authors:  T A Rich; A Schiller; H D Suit; H J Mankin
Journal:  Cancer       Date:  1985-07-01       Impact factor: 6.860

4.  The NIH Roadmap Epigenomics Program data resource.

Authors:  Lisa Helbling Chadwick
Journal:  Epigenomics       Date:  2012-06       Impact factor: 4.778

5.  Immunohistochemical analysis of the Brachyury protein in wild-type and mutant mouse embryos.

Authors:  A Kispert; B G Herrmann
Journal:  Dev Biol       Date:  1994-01       Impact factor: 3.582

6.  Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.

Authors:  S Vujovic; S Henderson; N Presneau; E Odell; T S Jacques; R Tirabosco; C Boshoff; A M Flanagan
Journal:  J Pathol       Date:  2006-06       Impact factor: 7.996

Review 7.  Optimization of radiotherapy for patients with cranial chordoma. A review of dose-response ratios for photon techniques.

Authors:  P T Tai; P Craighead; F Bagdon
Journal:  Cancer       Date:  1995-02-01       Impact factor: 6.860

8.  T (brachyury) gene duplication confers major susceptibility to familial chordoma.

Authors:  Xiaohong R Yang; David Ng; David A Alcorta; Norbert J Liebsch; Eamonn Sheridan; Sufeng Li; Alisa M Goldstein; Dilys M Parry; Michael J Kelley
Journal:  Nat Genet       Date:  2009-10-04       Impact factor: 38.330

9.  The T protein encoded by Brachyury is a tissue-specific transcription factor.

Authors:  A Kispert; B Koschorz; B G Herrmann
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

10.  A framework for variation discovery and genotyping using next-generation DNA sequencing data.

Authors:  Mark A DePristo; Eric Banks; Ryan Poplin; Kiran V Garimella; Jared R Maguire; Christopher Hartl; Anthony A Philippakis; Guillermo del Angel; Manuel A Rivas; Matt Hanna; Aaron McKenna; Tim J Fennell; Andrew M Kernytsky; Andrey Y Sivachenko; Kristian Cibulskis; Stacey B Gabriel; David Altshuler; Mark J Daly
Journal:  Nat Genet       Date:  2011-04-10       Impact factor: 38.330

View more
  19 in total

1.  [Novel molecular aspects of chordomas].

Authors:  S Scheil-Bertram
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  T (brachyury) is linked to a Mendelian form of neural tube defects in humans.

Authors:  Ranad Shaheen; Essam Alshail; Ahmed Alaqeel; Shinu Ansari; Farah Hindieh; Fowzan S Alkuraya
Journal:  Hum Genet       Date:  2015-07-26       Impact factor: 4.132

3.  Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.

Authors:  Dilys M Parry; Mary L McMaster; Norbert J Liebsch; Nicholas J Patronas; Martha M Quezado; Deborah Zametkin; Xiaohong R Yang; Alisa M Goldstein
Journal:  J Neurosurg       Date:  2020-06-19       Impact factor: 5.115

4.  Familial chordoma: A case report and review of the literature.

Authors:  K E Wang; Zhen Wu; Kaibing Tian; Liang Wang; Shuyu Hao; Liwei Zhang; Junting Zhang
Journal:  Oncol Lett       Date:  2015-09-09       Impact factor: 2.967

5.  Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma.

Authors:  Bing Xia; Kajal Biswas; Tzeh K Foo; Thiago T Gomes; Maximilian Riedel-Topper; Eileen Southon; Zhihua Kang; Yanying Huo; Susan Reid; Stacey Stauffer; Weiyin Zhou; Bin Zhu; Hela Koka; Sally Yepes; Seth A Brodie; Kristine Jones; Aurelie Vogt; Bin Zhu; Brian Carter; Neal D Freedman; Belynda Hicks; Meredith Yeager; Stephen J Chanock; Fergus Couch; Dilys M Parry; Alvaro N Monteiro; Alisa M Goldstein; Marcelo A Carvalho; Shyam K Sharan; Xiaohong R Yang
Journal:  Hum Mutat       Date:  2022-07-12       Impact factor: 4.700

6.  Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.

Authors:  Chetan Bettegowda; Stephen Yip; Sheng-Fu Larry Lo; Charles G Fisher; Stefano Boriani; Laurence D Rhines; Joanna Y Wang; Aron Lazary; Marco Gambarotti; Wei-Lien Wang; Alessandro Luzzati; Mark B Dekutoski; Mark H Bilsky; Dean Chou; Michael G Fehlings; Edward F McCarthy; Nasir A Quraishi; Jeremy J Reynolds; Daniel M Sciubba; Richard P Williams; Jean-Paul Wolinsky; Patricia L Zadnik; Ming Zhang; Niccole M Germscheid; Vasiliki Kalampoki; Peter Pal Varga; Ziya L Gokaslan
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

7.  UM-Chor1: establishment and characterization of the first validated clival chordoma cell line.

Authors:  John Henry Owen; Christine M Komarck; Anthony C Wang; Waleed M Abuzeid; Richard F Keep; Erin L McKean; Stephen Sullivan; Xing Fan; Mark E P Prince
Journal:  J Neurosurg       Date:  2017-04-21       Impact factor: 5.115

Review 8.  New Prospects for Molecular Targets for Chordomas.

Authors:  Mohammad Zeeshan Ozair; Pavan Pinkesh Shah; Dimitrios Mathios; Michael Lim; Nelson S Moss
Journal:  Neurosurg Clin N Am       Date:  2020-01-25       Impact factor: 2.509

9.  Putative oncogene Brachyury (T) is essential to specify cell fate but dispensable for notochord progenitor proliferation and EMT.

Authors:  Jianjian Zhu; Kin Ming Kwan; Susan Mackem
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-22       Impact factor: 11.205

10.  Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer.

Authors:  Sagar R Shah; Justin M David; Nathaniel D Tippens; Ahmed Mohyeldin; Juan C Martinez-Gutierrez; Sara Ganaha; Paula Schiapparelli; Duane H Hamilton; Claudia Palena; Andre Levchenko; Alfredo Quiñones-Hinojosa
Journal:  Cell Rep       Date:  2017-10-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.